Robert Lipetz

551 total citations
7 papers, 381 citations indexed

About

Robert Lipetz is a scholar working on Psychiatry and Mental health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert Lipetz has authored 7 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Psychiatry and Mental health, 2 papers in Pharmacology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert Lipetz's work include Attention Deficit Hyperactivity Disorder (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Pharmaceutical studies and practices (2 papers). Robert Lipetz is often cited by papers focused on Attention Deficit Hyperactivity Disorder (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Pharmaceutical studies and practices (2 papers). Robert Lipetz collaborates with scholars based in United States and United Kingdom. Robert Lipetz's co-authors include Douglas K. Kelsey, Joachim Wernicke, David Michelson, Jeffrey W. Brown, Humberto Quintana, John H. Heiligenstein, Haitao Gao, Donald A. Girod, Douglas E. Faries and Alan Kivitz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Therapeutics and Drug Safety.

In The Last Decade

Robert Lipetz

7 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Lipetz United States 6 200 128 76 64 52 7 381
Brett A. English United States 12 72 0.4× 120 0.9× 100 1.3× 31 0.5× 24 0.5× 19 456
B. Wasiak Poland 9 235 1.2× 60 0.5× 58 0.8× 25 0.4× 41 0.8× 13 547
John Guarino United States 12 299 1.5× 86 0.7× 107 1.4× 14 0.2× 20 0.4× 19 517
М. Л. Кукушкин Russia 10 143 0.7× 370 2.9× 68 0.9× 33 0.5× 62 1.2× 72 585
Jerrold G. Bernstein United States 10 106 0.5× 153 1.2× 37 0.5× 55 0.9× 25 0.5× 12 388
Rafael Sobrano Fais Brazil 11 86 0.4× 48 0.4× 53 0.7× 97 1.5× 60 1.2× 24 456
Michael Tocco United States 9 226 1.1× 50 0.4× 53 0.7× 24 0.4× 78 1.5× 62 453
J. Mintzer United States 7 266 1.3× 98 0.8× 25 0.3× 23 0.4× 15 0.3× 13 491
I. Zieleniuk France 11 109 0.5× 67 0.5× 64 0.8× 26 0.4× 22 0.4× 14 365
Sara Gibiino Italy 8 121 0.6× 117 0.9× 31 0.4× 55 0.9× 8 0.2× 15 420

Countries citing papers authored by Robert Lipetz

Since Specialization
Citations

This map shows the geographic impact of Robert Lipetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lipetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lipetz more than expected).

Fields of papers citing papers by Robert Lipetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lipetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lipetz. The network helps show where Robert Lipetz may publish in the future.

Co-authorship network of co-authors of Robert Lipetz

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lipetz. A scholar is included among the top collaborators of Robert Lipetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lipetz. Robert Lipetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
2.
Spencer, Thomas, Christopher J. Kratochvil, R. Bart Sangal, et al.. (2007). Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment. Journal of Child and Adolescent Psychopharmacology. 17(5). 689–699. 50 indexed citations
3.
4.
Sumner, Calvin R., Kory Schuh, Virginia K. Sutton, Robert Lipetz, & Douglas K. Kelsey. (2006). Placebo-Controlled Study of the Effects of Atomoxetine on Bladder Control in Children With Nocturnal Enuresis. Journal of Child and Adolescent Psychopharmacology. 16(6). 699–711. 41 indexed citations
5.
Schnitzer, Thomas J., et al.. (2005). Comparison of the COX‐inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee. Arthritis Care & Research. 53(6). 827–837. 53 indexed citations
6.
Seger, Wolfgang, et al.. (2004). Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scandinavian Journal of Rheumatology. 33(4). 257–266. 78 indexed citations
7.
Wernicke, Joachim, Douglas E. Faries, Donald A. Girod, et al.. (2003). Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults. Drug Safety. 26(10). 729–740. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brett A. English Breakdown of academic impact, for papers by B. Wasiak Breakdown of academic impact, for papers by John Guarino Breakdown of academic impact, for papers by М. Л. Кукушкин Breakdown of academic impact, for papers by Jerrold G. Bernstein Breakdown of academic impact, for papers by Rafael Sobrano Fais Breakdown of academic impact, for papers by Michael Tocco Breakdown of academic impact, for papers by J. Mintzer Breakdown of academic impact, for papers by I. Zieleniuk Breakdown of academic impact, for papers by Sara Gibiino
Rankless by CCL
2026